HORSHAM Pa. Sept. 26 2016 PRNewswire &160;Janssen Biotech Inc. announced today that the U.S. Food and Drug Administration FDA has approved STELARA&174; ustekinumab for the treatment of moderately to severely active Crohn's disease in adults 18 year...
↧